Joseph Roberson
E Palo Alto, CANPI 1932293123
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,113,510 of the $1,113,533 with a category attached, or 100.0%. Vital Connect, Inc accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest.
Across 5 payments — averaging $222,707 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vital Connect, Inc$1.1M
- AbbVie$23
Across 3 payments — averaging $147,464 each. An ownership or investment interest held by the physician or an immediate family member.
- Vital Connect, Inc$442K
What the payments were for
- Speaking & faculty fees$1,113,510100%
- Food & beverage$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vital Connect, Inc | 4 | $1,113,510 |
| AbbVie | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VITALPATCH RTM$1,113,510
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.